Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
Okamoto A, Nikaido T, Ochiai K, Takakura S, Saito M, Aoki Y, Ishii N, Yanaihara N, Yamada K, Takikawa O, Kawaguchi R, Isonishi S, Tanaka T, Urashima M.
Okamoto A, et al. Among authors: yanaihara n.
Clin Cancer Res. 2005 Aug 15;11(16):6030-9. doi: 10.1158/1078-0432.CCR-04-2671.
Clin Cancer Res. 2005.
PMID: 16115948